760 related articles for article (PubMed ID: 26261901)
21. Explaining the phenomenon of nitrate tolerance.
Münzel T; Daiber A; Mülsch A
Circ Res; 2005 Sep; 97(7):618-28. PubMed ID: 16195486
[TBL] [Abstract][Full Text] [Related]
22. Pentaerythrityl tetranitrate and nitroglycerin, but not isosorbide mononitrate, prevent endothelial dysfunction induced by ischemia and reperfusion.
Dragoni S; Gori T; Lisi M; Di Stolfo G; Pautz A; Kleinert H; Parker JD
Arterioscler Thromb Vasc Biol; 2007 Sep; 27(9):1955-9. PubMed ID: 17641250
[TBL] [Abstract][Full Text] [Related]
23. A new class of organic nitrates: investigations on bioactivation, tolerance and cross-tolerance phenomena.
Schuhmacher S; Schulz E; Oelze M; König A; Roegler C; Lange K; Sydow L; Kawamoto T; Wenzel P; Münzel T; Lehmann J; Daiber A
Br J Pharmacol; 2009 Sep; 158(2):510-20. PubMed ID: 19563531
[TBL] [Abstract][Full Text] [Related]
24. The oxidative stress concept of nitrate tolerance and the antioxidant properties of hydralazine.
Daiber A; Mülsch A; Hink U; Mollnau H; Warnholtz A; Oelze M; Münzel T
Am J Cardiol; 2005 Oct; 96(7B):25i-36i. PubMed ID: 16226933
[TBL] [Abstract][Full Text] [Related]
25. Organic nitrate tolerance and endothelial dysfunction: role of folate therapy.
Leopold JA; Loscalzo J
Minerva Cardioangiol; 2003 Aug; 51(4):349-59. PubMed ID: 12900717
[TBL] [Abstract][Full Text] [Related]
26. The antiplatelet effects of nitrates: is it of clinical significance in patients with cardiovascular disease?
Zhou RH; Frishman WH
Cardiol Rev; 2010; 18(4):198-203. PubMed ID: 20539103
[TBL] [Abstract][Full Text] [Related]
27. Human endothelial cells bioactivate organic nitrates to nitric oxide: implications for the reinforcement of endothelial defence mechanisms.
Feelisch M; Brands F; Kelm M
Eur J Clin Invest; 1995 Oct; 25(10):737-45. PubMed ID: 8557060
[TBL] [Abstract][Full Text] [Related]
28. Organic nitrates in cardiovascular disease.
Bode-Böger SM; Kojda G
Cell Mol Biol (Noisy-le-grand); 2005 Sep; 51(3):307-20. PubMed ID: 16191399
[TBL] [Abstract][Full Text] [Related]
29. Structure-activity relationship of organic nitrates for activation of guanylate cyclase.
Schröder H; Noack E
Arch Int Pharmacodyn Ther; 1987 Dec; 290(2):235-46. PubMed ID: 2895614
[TBL] [Abstract][Full Text] [Related]
30. The Endothelin Receptor Antagonist Macitentan Improves Isosorbide-5-Mononitrate (ISMN) and Isosorbide Dinitrate (ISDN) Induced Endothelial Dysfunction, Oxidative Stress, and Vascular Inflammation.
Steven S; Oelze M; Hausding M; Roohani S; Kashani F; Kröller-Schön S; Helmstädter J; Jansen T; Baum C; Iglarz M; Schulz E; Münzel T; Daiber A
Oxid Med Cell Longev; 2018; 2018():7845629. PubMed ID: 30687454
[TBL] [Abstract][Full Text] [Related]
31. Organic nitrates and nitrate resistance in diabetes: the role of vascular dysfunction and oxidative stress with emphasis on antioxidant properties of pentaerithrityl tetranitrate.
Oelze M; Schuhmacher S; Daiber A
Exp Diabetes Res; 2010; 2010():213176. PubMed ID: 21234399
[TBL] [Abstract][Full Text] [Related]
32. Effects of atrial natriuretic polypeptide and organic nitrates on levels of relaxation and cyclic nucleotide of canine coronary artery with and without endothelial injury.
Nakagawa H; Okumura K; Hashimoto H; Ito T; Ogawa K; Satake T
Heart Vessels; 1988; 4(1):19-25. PubMed ID: 2846505
[TBL] [Abstract][Full Text] [Related]
33. Impaired vasodilator response to organic nitrates in isolated basilar arteries.
Martens D; Kojda G
Br J Pharmacol; 2001 Jan; 132(1):30-6. PubMed ID: 11156558
[TBL] [Abstract][Full Text] [Related]
34. In vivo effects of pentaerythrityl-tetranitrate and isosorbide-5-mononitrate on the development of atherosclerosis and endothelial dysfunction in cholesterol-fed rabbits.
Kojda G; Stein D; Kottenberg E; Schnaith EM; Noack E
J Cardiovasc Pharmacol; 1995 May; 25(5):763-73. PubMed ID: 7543171
[TBL] [Abstract][Full Text] [Related]
35. Mechanisms of action of the organic nitrates in the treatment of myocardial ischemia.
Abrams J
Am J Cardiol; 1992 Sep; 70(8):30B-42B. PubMed ID: 1529924
[TBL] [Abstract][Full Text] [Related]
36. Characterization of the antioxidant properties of pentaerithrityl tetranitrate (PETN)-induction of the intrinsic antioxidative system heme oxygenase-1 (HO-1).
Daiber A; Münzel T
Methods Mol Biol; 2010; 594():311-26. PubMed ID: 20072927
[TBL] [Abstract][Full Text] [Related]
37. Pentaerythritol Tetranitrate Targeting Myocardial Reactive Oxygen Species Production Improves Left Ventricular Remodeling and Function in Rats With Ischemic Heart Failure.
Fraccarollo D; Galuppo P; Neuser J; Bauersachs J; Widder JD
Hypertension; 2015 Nov; 66(5):978-87. PubMed ID: 26351025
[TBL] [Abstract][Full Text] [Related]
38. Basic in vitro Characterization of the Vasodilatory Potential of 2-Aminoethyl Nitrate Fixed-Dose Combinations with Cilostazol, Metoprolol and Valsartan.
Oelze M; Welschof P; Knorr M; Tran LP; Ullmann E; Stamm P; Kröller-Schön S; Jansen T; Kopp M; Schulz E; Gori T; Burgin K; Scherhag A; Sartor D; Münzel T; Daiber A
Pharmacology; 2018; 101(1-2):54-63. PubMed ID: 28988245
[TBL] [Abstract][Full Text] [Related]
39. Inorganic nitrite and nitrate in cardiovascular therapy: A better alternative to organic nitrates as nitric oxide donors?
Münzel T; Daiber A
Vascul Pharmacol; 2018 Mar; 102():1-10. PubMed ID: 29174923
[TBL] [Abstract][Full Text] [Related]
40. Cardioprotective effects of glyceryl trinitrate: beyond vascular nitrate tolerance.
Csont T; Ferdinandy P
Pharmacol Ther; 2005 Jan; 105(1):57-68. PubMed ID: 15626455
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]